Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century (Q44306052)

1 December 2017

title

Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century (English)

1 reference

1 December 2017

0 references

Mona Jeffreys

1 reference

1 December 2017

Dianne Pulte

1 reference

1 December 2017

Maria Theresa Redaniel

series ordinal

1 reference

1 December 2017

Jenny Bird

series ordinal

1 reference

1 December 2017

publication date

4 February 2015

1 reference

European Journal of Haematology

1 December 2017

published in

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

540-545

1 reference

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 December 2017

cites work

1 reference

Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

21 January 2018

1 reference

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

21 January 2018

1 reference

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.

21 January 2018

1 reference

Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century

21 January 2018

1 reference

Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level

21 January 2018

1 reference

Survival of patients with chronic myelocytic leukemia: comparisons of estimates from clinical trial settings and population-based cancer registries

21 January 2018

1 reference

Long-term survival in chronic myelocytic leukemia after a first primary malignancy

21 January 2018

1 reference

Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century

21 January 2018

1 reference

Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study

21 January 2018

1 reference

Ageing is a risk factor in imatinib mesylate cardiotoxicity

21 January 2018

1 reference

Risk categories and refractory CLL in the era of chemoimmunotherapy

21 January 2018

1 reference

Projecting SEER cancer survival rates to the US: an ecological regression approach

21 January 2018

1 reference

Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications

21 January 2018

1 reference

Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland

21 January 2018

1 reference

Up-to-Date Long-Term Survival Curves of Patients With Cancer by Period Analysis

21 January 2018

1 reference

Regression models for relative survival

21 January 2018

1 reference

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2018

1 reference

21 January 2018

How I treat CLL up front

1 reference

Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing?

21 January 2018

1 reference

Patient factors, health care factors and survival from lung cancer according to ethnic group in the south of London, UK.

21 January 2018

1 reference

Breast cancer survival in South Asian women in England and Wales

21 January 2018

1 reference

Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups

21 January 2018

1 reference

Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults.

21 January 2018

1 reference

Insurance status is related to diffuse large B-cell lymphoma survival

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJH.12468

1 reference

1 December 2017

1 reference